Clinical Trial Update: Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nitazoxanide in combination with peginterferon alfa-2a and ribavirin for chronic hepatitis C completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Alinia (Nitazoxanide)
• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Romark Laboratories L.C. | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2014-01-06